NCT05124795 2024-01-17IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate CancerImmunic AGPhase 1 Terminated18 enrolled
NCT04634344 2022-07-11Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCDizal PharmaceuticalsPhase 1 Terminated16 enrolled